Clinical trial
A Placebo Control, Randomized, Double-blind, Multicenter Phase IV Study to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver (Damp-heat Obstruction Syndrome: Shi-Re-Zhong-Zu Zheng)
NCT06188611 is registered in ClinicalTrials.gov with Shandong New Time Pharmaceutical Co., LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Placebo Control, Randomized, Double-blind, Multicenter Phase IV Study to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver (Damp-heat Obstruction Syndrome: Shi-Re-Zhong-Zu Zheng)
- Lead sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 18, 2017
- Completion date
- November 8, 2018
- Enrollment
- 282 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
a phase iv trial to investigate the efficacy and safety of huazhi rougan granule in the treatment of non-alcoholic simple fatty liver